organization (TJC, 2005) . One of these goals was to standardize the abbreviations, acronyms, and symbols used in accredited institutions and to develop a list of abbreviations, acronyms, and symbols that should not be used in any order or medication-related documentation. Five specific "Do Not Use" terms were approved in 2005 and six other terms are under consideration (see Table 1 ).
Other Cautions
The ISMP and the FDA have both addressed the use of error-prone dosing terms. In 2006, the two organizations began a nationwide educational campaign designed to reduce the use of potentially harmful terms in all forms of medical communication (FDA, 2006) . Selected examples of easily mistaken dosing terms and recommendations for reducing the potential for associated errors are identified in Table 2 .
Drug Name Confusion
Using abbreviations or acronyms for proper drug names can, like dosing symbol errors, lead to misinterpretation. The examples of misinterpretations listed below serve as support for the caution that complete drugs names should be used in medication orders to avoid potential error in transcribing filling, labeling, or teaching patients (ISMP, 2007) .
• AZT-intended as zidovudine-misinterpreted as azathioprine or aztreonam.
• CPZ-intended as prochlorperazine-misinterpreted as chlorpromazine.
• DPT-intended as demerol-phenergan-thorazinemisinterpreted as diphtheria-pertussis-tetanus.
• HCL-intended as hydrochloric acid or hydrochloride and misinterpreted as potassium chloride.
• HCT-intended as hydrocortisone-misinterpreted as hydrochlorothiazide.
• MTX-intended as methotrexate-misinterpreted as mitoxantrone.
Any time that information about a patient's medication is communicated, there is a potential for error that occurs because of misinterpretation of abbreviations, acronyms, and dose designations. In the following discussion, corrective approaches for reducing the use of error-prone terms will be reviewed. Terms on the "Do Not Use" list are identified and the rationale for using "Tall Man" letters is addressed.
A ny time that information about a patient's medication is communicated, there is a potential for error. Communication errors can occur when a medication order is handwritten or computer generated, when transcribing an order, when transmitting an order by telephone, by computer or in person, when the drug container is labeled, when the medication is administered, and when patients are educated about their medications. The reasons for these errors are varied, but many are related to the use of abbreviations, acronyms, and dose designations that can be misinterpreted.
In the following discussion, recommendations from the Food and Drug Administration (FDA), The Joint Commission (TJC), and the Institute for Safe Medication Practices (ISMP) for reducing the use of error-prone terms will be reviewed. The current "Do Not Use" list is presented in Table 1. Table 2 identifies selected error-prone dosing terms and recommendations for correct terms. Drug acronyms that can be misinterpreted are identified, and Table 3 lists the drugs included in the "Name Differentiation Project" established by the Office of Generic Drugs.
Nurses in any healthcare setting may be writing medication orders, transcribing medication orders, or educating patients about their medication. Awareness of the possibility for medication communication errors and knowledge about acceptable terms can serve as an important safety factor to protect patients from potential harm.
The "Do Not Use" List
The TJC (formerly the Joint Commission on Accreditation of Healthcare Organizations) has developed "National Patient Safety Goals" that address a wide variety of subjects specifically aimed at improving patient safety in almost every type of healthcare Period after the "Q" and "O" "Every other day" (every other day) mistaken for "1" or "I"
Trailing "0" (x.0 mg) a Decimal point may be missed: Write X mg Lack of leading zero (.X mg) "2.0 mg" misinterpreted as "20 mg" Write 0.X mg ".20 mg" misinterpreted as "20 mg"
MS
Can mean morphine sulfate or Write "morphine sulfate" magnesium sulfate MSO 4 and MgSO 4 Can be confused for one another Write "magnesium sulfate"
Under Consideration Rationale Correct Form Ͼ (greater than) Mistaken for the number Write "greater than" Ͻ (less than) " 7" or the letter " L"-confused Write "less than" for one another
Abbreviations for drug
Misinterpretation of one Write drug names in full names (see below) drug for another
Apothecary units Unfamiliar to many, Use metric units confused for metric units @ Mistaken for number "2" Write "at" cc Mistaken for U (units) Write "ml" or "milliliters" g Mistaken for mg (milligrams) Write "mcg" or "micrograms" results in 1,000-fold overdose • IV Vanc-intended as intravenous vancomycinmisinterpreted as (Invanz).
In some cases, the use of the complete drug name may not be enough to prevent errors because two drugs may have such similar names that they are easily confused for one another. In 2001, the FDA/Office of Generic Drugs began a "Name Differentiation Project." This program was designed to promote the use of "Tall Man" letters on product labeling to visually differentiate between drugs of very similar names by using small and large letters and bolding in the drug name. While this program has had mixed results with drug manufacturers, some hospitals are using the "Tall Man" letters on their own labels, and many drug information references are using the "Tall Man" letters as recommended by the FDA (FDA, 2008; Turkoski, Lance, & Bonfiglio, 2008) . A list of recommended "Tall Man" revisions is found in Table 3 .
Conclusion
After reviewing the various terms, acronyms, abbreviations, and drug names that are potentially error-prone, it becomes very clear that establishing uniformity in medication communication is vital to patient safety. The FDA, ISMP, and TJC are all primary motivators in establishing guidelines for medication safety. However, it is the professionals involved with medication orders who can make changes that will decrease the potential for error. Nurses are involved at many points in the communication pathway-from writing a medication order to the end point of teaching and administering the medication to patients. Nurses who are aware of the potential error-prone terms and take action to incorporate corrective approaches will add one more positive approach to increasing patient safety.
